Department of Intensive Care Unit, Tongzhou People's Hospital, Nantong 226300, China.
World J Emerg Med. 2012;3(1):29-34. doi: 10.5847/wjem.j.issn.1920-8642.2012.01.005.
Early withdrawal of invasive mechanical ventilation (IMV) followed by noninvasive MV (NIMV) is a new strategy for changing modes of treatment in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) with acute respiratory failure (ARF). Using pulmonary infection control window (PIC window) as the switch point for transferring from invasive to noninvasive MV, the time for early extubation can be more accurately judged, and therapy efficacy can be improved. This study aimed to prospectively investigate the clinical effectiveness of fiberoptic bronchscopy (FOB) in patients with AECOPD during sequential weaning of invasive-noninvasive MV.
Since July 2006 to January 2011, 106 AECOPD patients with ARF were treated with comprehensive medication and IMV after hospitalization. Patients were randomly divided into two groups according to whether fiberoptic bronchoscope is used (group A, n=54) or not (group B, n=52) during sequential weaning from invasive to noninvasive MV. In group A, for sputum suction and bronchoalveolar lavage (BAL), a fiberoptic bronchoscope was put into the airway from the outside of an endotracheal tube, which was accompanied with uninterrupted use of a ventilator. After achieving PIC window, patients of both groups changed to NIMV mode, and weaned from ventilation. The following listed indices were used to compare between the groups after treatment: 1) the occurrence time of PIC, the duration of MV, the length of ICU stay, the success rate of weaning from MV for the first time, the rate of reventilation and the occurrence rate of ventilator-associated pneumonia (VAP); 2) the convenience and safety of FOB manipulation. The results were compared using Student's t test and the Chi-square test.
The occurrence time of PIC was (5.01±1.49) d, (5.87±1.87) d in groups A and B, respectively (P<0.05); the duration of MV was (6.98±1.84) d, (8.69±2.41) d in groups A and B, respectively (P<0.01); the length of ICU stay was (9.25±1.84) d, (11.10±2.63) d in groups A and B, respectively (P<0.01); the success rate of weaning for the first time was 96.30%, 76.92% in groups A and B, respectively (P<0.01); the rate of reventilation was 5.56%, 19.23% in groups A and B, respectively (P<0.05); and the occurrence rate of VAP was 3.70%, 23.07% in groups A and B, respectively (P<0.01). Moreover, it was easy and safe to manipulate FOB, and no side effect was observed.
The application of FOB in patients with AECOPD during sequential weaning of invasive-noninvasive MV is effective in ICU. It can decrease the duration of MV and the length of ICU stay, increase the success rate from weaning MV for the first time, reduce the rate of reventilation and the occurrence rate of VAP. In addition, such a method is convenient and safe in patients of this kind.
有创机械通气(IMV)早期撤机后序贯无创通气(NIMV)是一种治疗慢性阻塞性肺疾病急性加重伴急性呼吸衰竭(AECOPD)患者的新策略。使用肺部感染控制窗(PIC 窗)作为从有创到无创通气转换的切换点,可以更准确地判断早期拔管时间,并提高治疗效果。本研究旨在前瞻性研究纤维支气管镜(FOB)在 AECOPD 患者有创-无创序贯撤机中的临床效果。
2006 年 7 月至 2011 年 1 月,106 例 AECOPD 合并 ARF 患者住院后给予综合药物治疗和 IMV。根据在有创到无创序贯撤机过程中是否使用纤维支气管镜(A 组,n=54)将患者随机分为两组。在 A 组中,为了进行吸痰和支气管肺泡灌洗(BAL),纤维支气管镜从气管插管的外部插入气道,同时不间断地使用呼吸机。达到 PIC 窗后,两组患者均改为 NIMV 模式,并进行通气撤机。治疗后比较两组以下指标:1)PIC 发生时间、MV 时间、ICU 住院时间、首次 MV 撤机成功率、再通气率和呼吸机相关性肺炎(VAP)发生率;2)FOB 操作的便利性和安全性。采用 Student's t 检验和卡方检验进行比较。
A 组和 B 组的 PIC 发生时间分别为(5.01±1.49)d 和(5.87±1.87)d(P<0.05);MV 时间分别为(6.98±1.84)d 和(8.69±2.41)d(P<0.01);ICU 住院时间分别为(9.25±1.84)d 和(11.10±2.63)d(P<0.01);首次撤机成功率分别为 96.30%和 76.92%(P<0.01);再通气率分别为 5.56%和 19.23%(P<0.05);VAP 发生率分别为 3.70%和 23.07%(P<0.01)。此外,FOB 操作简便、安全,无不良反应。
纤维支气管镜在 AECOPD 患者有创-无创序贯撤机中的应用在 ICU 中是有效的。它可以缩短 MV 时间和 ICU 住院时间,提高首次撤机成功率,降低再通气率和 VAP 发生率。此外,该方法在这类患者中操作方便、安全。